Sebastian Krueger

Title: Sebastian Krueger: Innovator in Pharmaceutical Chemistry

Introduction

Sebastian Krueger is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate the glucocorticoid receptor. With a total of 7 patents to his name, Krueger's work is recognized for its potential impact on medical treatments.

Latest Patents

Among his latest patents, Krueger has developed "Substituted pyrrolidine amides II," which relates to compounds that act as modulators of the glucocorticoid receptor. These compounds can be utilized in the treatment and/or prophylaxis of disorders that are at least partially mediated by this receptor. Another significant patent is "Substituted pyrrolidine amides V," which also involves compounds according to a specific general formula.

Career Highlights

Throughout his career, Sebastian Krueger has worked with prominent companies in the pharmaceutical industry, including Grünenthal GmbH. His innovative work has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Krueger has collaborated with several professionals in his field, including Florian Jakob and Jo Alen. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Sebastian Krueger's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.